___

• Akgül A (2003). Tıbbi Araştırmalarda İstatistiksel Analiz Teknikleri: SPSS Uygulamaları. 2. baskı, Emek Ofset Ltd. Şti, Ankara.
• Armutçu F, Söğüt S, Gürel A, Kart L, Coşkun Ö (2004). Bleomisin verilen ratlarda plazma ve eritrositlerin oksidan ve antioksidan durumu. Erdostein ve vitamin E’nin koruyucu rolü. Türk Hematoloji-Onkoloji Dergisi, 14(4), 205–213.
• Barnes PJ, Belvisi MG (1993). Nitric oxide and lung disease. Thorax, 48(10), 1034–1043.
• Bancroft JD, Cook HC (1984). Manual of Histological Techniques. Churchill-Livingstone, New York.
• Behera D, Kaur S, Sathyanarayana G, Bhatnagar A, Majumdar S (2002). Nitric oxide derivate in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis. Indian J Chest Dis Sci, 44(1), 21–24.
• Byung PY (1994). Cellular defenses againt damage from reactive species. Am J Physiol, 74, 139–172.
• Ellis JL, Undem BJ (1992). Inhibition by L-NG-Nitro-L-Arginine of nonadrenergic-noncholinergic-mediated relaxion of human ısolated central an pherpheral airways. Am Rev Respir Dis, 146, 1543–1547.
• Giri SN, Biring I, Nguyen T, Wang Q, Hyde DM (2002). Abrogation of bleomycin-induced lung fibrosis by nitric oxide synthase inhibitor, aminoguanidine in mice. Nitric Oxide, 7(2), 109–118.
• Jefferies A, Turley A (1999). Perfusion and gas transport. Mosby’s crash course “Respiratory System”. London, Mosby Ltd, 59–85.
• Jules-Elysee K, White DA (1990). Bleomycin-induced pulmonary toxicity. Clin Chest Med, 11, 1–20.
• Kanazawa H, Shoji S, Yamada M et al. (1997). Increased levels of nitric oxide derivates in induced sputum in patients with asthma. J Allergy Clin Immunol, 99(5), 624–629.
• Koçyiğit E (2002). İnterstisyel akciğer hastalıkları ve kronik solunum yetmezliği. Solunum, 4(2), 343–446.
• Lowenstein CJ, Dinerman JL, Snyder SH (1994). Nitric oxide: A physiologic messenger. Ann Intern Med, 120, 227–237.
• Mizutani T, Layon AJ (1996). Clinical applications of nitric oxide. Chest, 110(2), 506–524.
• Montaldo C, Cannas E, Ledda M, Rosetti L, Atzori L (2002). Broncoalveolar glutathione and nitrite/nitrate in idiopathic pulmonary fibrosis and sarcoidosis. Sarcodiosis Vasc Diffuse Lung Dis, 19(1), 54–58.
• Nussler AK, Billiar TR: Inflammation immunoregulation and inducible nitric oxide synthase. J Leukoc Biol, 9, 109–137, 1993.
• Özyurt H, Söğüt S, Kart L (2004). Unhibitory effect of caffeic acid phanethyester on bleomycine-induced lung fibrosis in rats. Clin Chim Acta, 339, 65–75.
• Palmer RMJ, Asthon DS, Moncada S (1988). Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature, 333, 664–666.
• Ruppel GL (1998). Manual of Pulmonary Function Testing. 7th ed. 133–158, St. Louis, Missouri.
• Saleh D, Barnes PJ, Giaid A (1997). Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 155(5), 1763–1769.
• Shapiro BA, Peruzzi WT, Templin R (1994). Arterial oxygenation. In, Shapiro BA, Peruzzi WT, Templin R (Eds): Clinical application of blood gases. 5th edition. pp. 33-54. Mosby, St Louis.
• Sthar HM (1977). Analytical Toxicology Methods Manual. 68-71, Iowa State University Press. Ames, Iowa, USA.
• Şahin A (1995). Arteryel kan gazları. Barış YI (Ed): Solunum hastalıklarında temel yaklaşım. 76–86, Akciğer Hastalıkları Vakfı Yayınları, Ankara. LT Tanoue (1998). Pulmonary toxicity associated with chemotherapeutic agents. In, Fishman AP (Ed): Pulmonary Diseases and Disorders. 3rd ed. Mc Grawhill Vol (1), New York, 66, 1003–1016.
• Tosun GA, Tutluoğlu B (2000). Arter kan gazları ve asit baz dengesi. Solunum, 2, 202–213.
• Tutluoğlu B, Gümüştaş MK, Müsellim G ve ark. (2000). Bronşiyal astımda nazal lavajda nitrik oksit metabolitleri. Turk Arch Otolaryngol, 38(1), 42–50.
• Yenel F (1996). Arteryel Kan Gazları. Akciğer Fonksiyon Testleri. 57– 66, Dilek Matbaası, İstanbul.
• Yücel D, Aydoğdu S, Çehreli Ş ve ark. (1998). Increased oxidative stress in dilated cardiomyopathic heart failure. Clin Chem, 44, 148–154.